NuVasive (NUVA) jumps 11.7% after disclosing that preliminary 2012 revenues climbed 15% to...
Wednesday, January 9, 9:50 AM ETNuVasive (NUVA) jumps 11.7% after disclosing that preliminary 2012 revenues climbed 15% to $619M, above previous guidance of $601-606M and analyst consensus of $604.4M. NuVasive expects 2013 sales of $655M vs Street forecasts of $638.16M. "We anticipate that our market share taking strategy and momentum can be sustained in 2013," says CEO Alex Lukianov, who's due to present at the JPM Healthcare conference today. (PR)
Latest Earnings Articles